Evidence map›Paper›PMID 31243362›Full record

ArticleNature2019

Immune evasion before tumour invasion in early lung squamous carcinogenesis.

Céline Mascaux, Mihaela Angelova, Angela Vasaturo, Jennifer Beane, Kahkeshan Hijazi, Geraldine Anthoine, Bénédicte Buttard, Françoise Rothe, Karen Willard-Gallo, Annick Haller and 5 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 203 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
203citing papers in PubMed, 1 pooled it
20.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

203 citing papers in PubMed, 1 synthesis or guideline pooled it, 331 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Immunoscore based on CD3American journal of cancer research · 2026
    Article
  18. Review
  19. Article
  20. Article

143 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Céline Mascaux *Department of Intensive Care and Thoracic Oncology, Jules Bordet Institute, Centre des Tumeurs de l'Université Libre de Bruxelles (ULB), ULB, Brussels, Belgium. celine.mascaux@chru-strasbourg.fr.
Mihaela Angelova *INSERM, Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France.
Angela VasaturoINSERM, Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France.
Jennifer BeaneSection of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Kahkeshan HijaziSection of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Geraldine AnthoineDepartment of Intensive Care and Thoracic Oncology, Jules Bordet Institute, Centre des Tumeurs de l'Université Libre de Bruxelles (ULB), ULB, Brussels, Belgium.
Bénédicte ButtardINSERM, Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France.
Françoise RotheBreast Cancer Translational Research Laboratory, Jules Bordet Institute, Centre des Tumeurs de l'Université Libre de Bruxelles (ULB), ULB, Brussels, Belgium.
Karen Willard-GalloLaboratory of Molecular Immunology, Jules Bordet Institute, Centre des Tumeurs de l'Université Libre de Bruxelles (ULB), ULB, Brussels, Belgium.
Annick HallerDepartment of Pathology, Jules Bordet Institute, Centre des Tumeurs de l'Université Libre de Bruxelles (ULB), ULB, Brussels, Belgium.
Vincent NinaneDepartment of Pulmonary Medicine, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), ULB, Brussels, Belgium.
Arsène BurnyLaboratory of Molecular and Cellular Biology, Faculté Universitaire des Sciences Agronomiques de Gembloux (FUSAGx), Gembloux, Belgium.
Jean-Paul SculierDepartment of Intensive Care and Thoracic Oncology, Jules Bordet Institute, Centre des Tumeurs de l'Université Libre de Bruxelles (ULB), ULB, Brussels, Belgium.
Avi SpiraSection of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Jérôme GalonINSERM, Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France. jerome.galon@crc.jussieu.fr.
Université Libre de Bruxelles · BEBoston University · USInserm · FRDélégation Paris 5 · FRGembloux Agro-Bio Tech · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early detection and treatment are critical for improving the outcome of patients with cancer

Indexed as

AdultAgedCarcinogenesisCarcinoma, Squamous CellEarly Detection of CancerEpithelial-Mesenchymal TransitionFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm InvasivenessTumor EscapeTumor Microenvironment

Identifiers

PMID31243362
OpenAlexW2954157188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.